Advancements, Challenges, and Future Directions of Stem Cell Therapies in Skin Cancer
DOI:
https://doi.org/10.54097/pqa89q67Keywords:
Skin cancer, stem cell therapy, iPSCs.Abstract
Skin cancer, one of the most prevalent malignancies worldwide, remains a significant challenge for global healthcare systems. Despite the availability of numerous treatments, many patients face suboptimal outcomes and a range of adverse effects. In the quest for more effective therapeutic strategies, attention has turned to stem cells, renowned for their unique ability to differentiate and regenerate. These attributes position them as potential game-changers in skin cancer therapeutics. This comprehensive review delves into the multifaceted world of skin stem cells, exploring their diverse types and the roles they play in tissue repair and regeneration. The current landscape of stem cell utilization in skin cancer therapy is examined, highlighting inherent limitations and proposing innovative solutions. By looking into future advancements, the review offers a panoramic view of stem cell applications across various global contexts. The aim is to amalgamate the existing body of knowledge, pinpoint areas awaiting further exploration, and pave the way for more effective strategies in skin cancer management.
Downloads
References
Prodinger CM, Reichelt J, Bauer JW, Laimer M. Current and Future Perspectives of Stem Cell Therapy in Dermatology. Annals of dermatology, 2017, 29 (6): 667–687.
Chu GY, ChenYF, ChenHY, et al. Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues. Journal of food and drug analysis, 2018, 26 (1): 14–20.
Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther, 2019, 20 (11): 1366-1379.
US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent Skin Cancer. Washington (DC): Office of the Surgeon General (US); 2014. Skin Cancer as a Major Public Health Problem. Available from: https://www.ncbi.nlm.nih.gov/books/NBK247164/.
Ciążyńska M, Kamińska-Winciorek G, Lange D, et al. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep, 2021, 11 (1): 4337.
Aly RM. Current state of stem cell-based therapies: an overview. Stem Cell Investigation, 2020, 7: 8.
Petrus-Reurer S, Romano M, Howlett S, et al. Immunological considerations and challenges for regenerative cellular therapies. Communications Biology, 2021, 4 (1): 798.
Patton EE, Mueller KL, Adams DJ, et al. Melanoma models for the next generation of therapies. Cancer Cell, 2021, 39 (5): 610-631.
Dearman BL, Boyce ST, Greenwood JE. Advances in Skin Tissue Bioengineering and the Challenges of Clinical Translation. Frontiers in Surgery, 2021, 8: 640879.
Sato Y, Bando H, Di Piazza M, et al. Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. Cytotherapy, 2019, 21 (11): 1095-1111.
Lee AS, Tang C, Rao MS, et al. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med, 2013, 19 (8): 998-1004.
Peterson SE, Garitaonandia I, Loring JF. The tumorigenic potential of pluripotent stem cells: What can we do to minimize it? Bioessays, 2016, 38 Suppl 1: S86-95.
Lappin T, Cheng T. An urgent need for standardization of stem cells and stem cell-derived products toward clinical applications. Stem Cells Transl Med, 2021, 10 Suppl 2 (Suppl 2): S1-S3.
Lovell-Badge R, Anthony E, Barker RA, et al. ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. Stem Cell Reports, 2021, 16 (6): 1398-1408.
Cao J, Hao J, Wang L, et al. Developing standards to support the clinical translation of stem cells. Stem Cells Transl Med, 2021, 10 Suppl 2 (Suppl 2): S85-S95.
Prodinger CM, Reichelt J, Bauer JW, et al. Current and Future Perspectives of Stem Cell Therapy in Dermatology. Ann Dermatol, 2017, 29 (6): 667-687.
Wilkinson AC, Ishida R, Kikuchi M, et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature, 2019, 571 (7763): 117-121.
Karam D, Kumar S. Post-Transplant Maintenance Treatment Options in Multiple Myeloma. Oncol Ther, 2021, 9 (1): 69-88.
Allen UD, Preiksaitis JK. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant, 2019, 33 (9): e13652.
Leonard A, Tisdale JF. Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced. Expert Rev Hematol, 2018, 11 (7): 547-565.
Álvarez Z, Ortega JA, Sato K, et al. Artificial extracellular matrix scaffolds of mobile molecules enhance maturation of human stem cell-derived neurons. Cell Stem Cell, 2023, 30 (2): 219-238.e14.
Fang Z, Chen P, Tang S, et al. Will mesenchymal stem cells be future directions for treating radiation-induced skin injury? Stem Cell Res Ther, 2021, 12: 179.
Debela DT, Muzazu SG, Heraro KD, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med, 2021, 9: 20503121211034366.
Zakrzewski W, Dobrzyński M, Szymonowicz M, et al. Stem cells: past, present, and future. Stem Cell Res Ther, 2019, 10: 68.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
